Biolux Technology will present its FDA-cleared OrthoPulse device at the 2025 AAO Annual Session in Philadelphia, highlighting its use of near-infrared light to accelerate orthodontic treatment.
Biolux Research, manufacturers of OrthoPulse, announced the addition of three new US-based sales territory mangers as part of the company’s sales and commercialization efforts.
Dr Roberto Hernández-Orsini has been appointed president of the American Board of Orthodontics for the 2025-2026 term, with Dr P. Emile Rossouw named president-elect and Dr Anthony M. Puntillo as secretary/treasurer.
Biolux Research plans to release the OrthoPulse device, which uses photobiomodulation to reduce orthodontic treatment time, in the United States in early 2015, once FDA clearance is obtained.
Read More
Forty-four Schulman members will evaluate OrthoPulse, an intraoral device that incorporates proprietary photobiomodulation technology and is designed to be used with any form of orthodontic mechanics to significantly reduce patient treatment timelines, in their practices.
Read More
The joint venture will bring about the manufacture and commercialization of the OrthoPulse accelerated tooth movement technology.
Read More
Combining clear aligners and the intraoral Biolux technology, patients may be able to achieve both cosmetic benefit and reductions in treatment timeline.
Read More
As VP of Global Sales and Marketing, Nabors will be responsible for the commercialization of the company’s OrthoPulse technology.
Read More